Corvus Pharmaceuticals (CRVS) News Today → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free CRVS Stock Alerts $1.68 -0.23 (-12.04%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWilliam Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stockmarketbeat.com - May 7 at 6:58 PMCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 7 at 3:51 PMCorvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Resultsfinanznachrichten.de - May 7 at 10:51 AMQ1 2024 Corvus Pharmaceuticals Inc Earnings Callfinance.yahoo.com - May 7 at 10:51 AMOppenheimer Increases Corvus Pharmaceuticals (NASDAQ:CRVS) Price Target to $8.00marketbeat.com - May 7 at 8:32 AMCorvus Pharmaceuticals Inc (CRVS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...finance.yahoo.com - May 7 at 5:50 AMCorvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Resultsglobenewswire.com - May 6 at 4:01 PMCorvus Pharmaceuticals (CRVS) Scheduled to Post Earnings on Mondayamericanbankingnews.com - May 4 at 2:36 AMCorvus Pharmaceuticals (CRVS) Set to Announce Earnings on Mondaymarketbeat.com - May 3 at 10:33 AMCorvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024globenewswire.com - May 2 at 4:02 PMCorvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offeringglobenewswire.com - May 2 at 8:30 AMCorvus Pharmaceuticals (NASDAQ:CRVS) Shares Pass Below 50-Day Moving Average of $1.83americanbankingnews.com - May 1 at 5:40 AMCorvus Pharmaceuticals, Inc. (CRVS)finance.yahoo.com - April 24 at 9:28 PMHere's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeksfinance.yahoo.com - April 17 at 12:53 PMCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Short Interest Down 6.0% in Marchmarketbeat.com - April 16 at 4:34 PMCorvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitisglobenewswire.com - April 9 at 4:01 PMCorvus Pharmaceuticals, Inc. to Post FY2024 Earnings of ($0.35) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:CRVS)marketbeat.com - April 4 at 9:14 AMCantor Fitzgerald Reaffirms Overweight Rating for Corvus Pharmaceuticals (NASDAQ:CRVS)marketbeat.com - April 1 at 12:23 PMMizuho Reiterates Neutral Rating for Corvus Pharmaceuticals (NASDAQ:CRVS)marketbeat.com - March 27 at 2:13 PMCorvus Pharmaceuticals, Inc. (CRVS) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 21 at 5:14 PMCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 21 at 5:14 PMCorvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 21 at 7:29 AMCorvus Pharmaceuticals (NASDAQ:CRVS) Price Target Lowered to $7.00 at Oppenheimermarketbeat.com - March 20 at 8:22 AMQ4 2023 Corvus Pharmaceuticals Inc Earnings Callfinance.yahoo.com - March 20 at 6:37 AMCorvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsstockhouse.com - March 19 at 10:03 PMCorvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 19 at 4:02 PMCorvus Pharmaceuticals (CRVS) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - March 18 at 7:39 AMCRVS Apr 2024 4.000 putfinance.yahoo.com - March 16 at 3:41 PMCorvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024globenewswire.com - March 13 at 4:02 PMWe Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth Carefullyfinance.yahoo.com - March 9 at 1:52 PMCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Short Interest Down 8.0% in Februarymarketbeat.com - March 4 at 11:57 AMCRVS Mar 2024 3.000 putfinance.yahoo.com - February 17 at 7:36 AMCorvus Edges up on Disclosing Datamsn.com - February 12 at 6:33 PMCorvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Upfinance.yahoo.com - February 12 at 1:33 PMCorvus Pharmaceuticals Shares Rise on Orphan Drug Designationmarketwatch.com - February 8 at 6:17 PMCorvus lymphoma drug gets FDA orphan drug statusmsn.com - February 8 at 6:17 PMCorvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphomafinance.yahoo.com - February 8 at 6:17 PMCorvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officerfinance.yahoo.com - February 6 at 9:12 PMCorvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchellfinance.yahoo.com - January 23 at 7:04 PMIndividual investors in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) are its biggest bettors, and their bets paid off as stock gained 20% last weekfinance.yahoo.com - January 5 at 9:48 AMMaintaining Hold Rating on Corvus Pharmaceuticals Amid Steady but Unspectacular Clinical Progressmarkets.businessinsider.com - December 13 at 11:15 PMAre Medical Stocks Lagging Corvus Pharmaceuticals (CRVS) This Year?msn.com - December 7 at 3:48 PMIs Corvus Pharmaceuticals (CRVS) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - November 21 at 12:34 PMCorvus Pharmaceuticals Inc CRVSmorningstar.com - November 9 at 8:39 AMCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 8 at 2:58 PMQ3 2023 Corvus Pharmaceuticals Inc Earnings Callfinance.yahoo.com - November 8 at 9:57 AMCorvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 7 at 5:35 PMCorvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Expositionfinance.yahoo.com - November 2 at 10:24 AMCorvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to T Cell-Mediated Inflammatory and Immune Diseasesfinance.yahoo.com - November 1 at 11:19 PMCorvus Pharmaceuticals to Provide Business Update and Report Third Quarter Financial Results on November 7, 2023finance.yahoo.com - October 31 at 8:25 PM Get Corvus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVS and its competitors with MarketBeat's FREE daily newsletter. Email Address AI “wealth window” is closing June 25th (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… CRVS Media Mentions By Week CRVS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVS News Sentiment▼0.100.38▲Average Medical News Sentiment CRVS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVS Articles This Week▼161▲CRVS Articles Average Week Get Corvus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Jaguar Health News Hookipa Pharma News Connect Biopharma News LifeVantage News Tempest Therapeutics News Affimed News Leap Therapeutics News Marinus Pharmaceuticals News Reviva Pharmaceuticals News Anebulo Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorGold Set to EXPLODE!Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI “wealth window” is closing June 25thParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
